大麻医薬品市場：ブランド、製品タイプ、流通チャネル、用途別-2023-2030年の世界予測

大麻医薬品の世界市場は、2023年に14億4,934万米ドル、CAGR18.73％で大きく成長し、2030年には48億2,656万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の大麻医薬品市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.大麻医薬品の世界市場規模および予測は？

2.予測期間中、世界の大麻医薬品市場を形成するCOVID-19の阻害要因と影響は？

3.大麻医薬品の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.大麻医薬品の世界市場における競争戦略は？

5.大麻医薬品の世界市場における技術動向と規制の枠組みは？

6.大麻医薬品の世界市場における主要ベンダーの市場シェアは？

7.大麻医薬品の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で医療用大麻の合法化が増加
    • カンナビジオールの医学的利点とその治療効果についての意識の高まり
    • 炎症、慢性疼痛、睡眠障害などのさまざまな適応症に対する大麻ベースの医薬品の使用が増加
  • 抑制要因
    • 医療大麻に伴う高額な価格
  • 機会
    • 製薬会社によるCBDおよびカンナビノイド規制の開発への投資の増加
    • イノベーションと新製品の発売
  • 課題
    • 市場ではさまざまな代替品が入手可能
• 市場動向
• COVID-19の累積的な影響
• ロシア・ウクライナ紛争の累積的影響
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制の枠組み
• 顧客のカスタマイズ

第6章 大麻医薬品市場ブランド別

• エピディオレックス
• サティベックス

第7章 大麻医薬品市場：製品タイプ別

• 軟膏とクリーム
• 固体および溶解性粉末および油

第8章 大麻医薬品市場：流通チャネル別

• 病院薬局
• オンライン薬局
• 小売薬局

第9章 大麻医薬品市場：用途別

• 関節炎
• がん
• てんかん
• 片頭痛

第10章 南北アメリカの大麻医薬品市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の大麻医薬品市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの大麻医薬品市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• FPNVポジショニングマトリクス
• 市場シェア分析：主要企業別
• 競合シナリオ分析：主要企業別

第14章 掲載企業一覧

第15章 付録

• ディスカッションガイド
• ライセンスと価格について

LIST OF FIGURES

• FIGURE 1. CANNABIS PHARMACEUTICALS MARKET RESEARCH PROCESS
• FIGURE 2. CANNABIS PHARMACEUTICALS MARKET SIZE, 2022 VS 2030
• FIGURE 3. CANNABIS PHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2022 VS 2030 (%)
• FIGURE 5. CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2022 VS 2030 (%)
• FIGURE 6. CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
• FIGURE 7. CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
• FIGURE 8. CANNABIS PHARMACEUTICALS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 9. CANNABIS PHARMACEUTICALS MARKET DYNAMICS
• FIGURE 10. CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 18. CANNABIS PHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 19. CANNABIS PHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. CANNABIS PHARMACEUTICALS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. CANNABIS PHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 5. CANNABIS PHARMACEUTICALS MARKET SIZE, BY EPIDIOLEX, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. CANNABIS PHARMACEUTICALS MARKET SIZE, BY SATIVEX, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. CANNABIS PHARMACEUTICALS MARKET SIZE, BY OINTMENTS & CREAMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. CANNABIS PHARMACEUTICALS MARKET SIZE, BY SOLIDS AND DISSOLVABLE POWDER & OIL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 11. CANNABIS PHARMACEUTICALS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. CANNABIS PHARMACEUTICALS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. CANNABIS PHARMACEUTICALS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 15. CANNABIS PHARMACEUTICALS MARKET SIZE, BY ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. CANNABIS PHARMACEUTICALS MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. CANNABIS PHARMACEUTICALS MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. CANNABIS PHARMACEUTICALS MARKET SIZE, BY MIGRAINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. CANADA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 33. CANADA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 34. CANADA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 35. CANADA CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 37. MEXICO CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 46. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 47. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. AUSTRALIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 51. AUSTRALIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 52. AUSTRALIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 53. AUSTRALIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. CHINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 55. CHINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 56. CHINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 57. CHINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. INDIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 59. INDIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 60. INDIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 61. INDIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. INDONESIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 63. INDONESIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 64. INDONESIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 65. INDONESIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. JAPAN CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 67. JAPAN CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 68. JAPAN CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 69. JAPAN CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. MALAYSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 71. MALAYSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 72. MALAYSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 73. MALAYSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. PHILIPPINES CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 75. PHILIPPINES CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 76. PHILIPPINES CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 77. PHILIPPINES CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. SINGAPORE CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 79. SINGAPORE CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 80. SINGAPORE CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 81. SINGAPORE CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. SOUTH KOREA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 83. SOUTH KOREA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 84. SOUTH KOREA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH KOREA CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. TAIWAN CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 87. TAIWAN CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 88. TAIWAN CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 89. TAIWAN CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. THAILAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 91. THAILAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 92. THAILAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 93. THAILAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. VIETNAM CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 95. VIETNAM CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 96. VIETNAM CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 97. VIETNAM CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 99. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 100. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 101. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 102. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. DENMARK CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 104. DENMARK CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 105. DENMARK CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 106. DENMARK CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 107. EGYPT CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 108. EGYPT CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 109. EGYPT CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 110. EGYPT CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. FINLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 112. FINLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 113. FINLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 114. FINLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. FRANCE CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 116. FRANCE CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 117. FRANCE CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 118. FRANCE CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. GERMANY CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 120. GERMANY CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 121. GERMANY CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 122. GERMANY CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. ISRAEL CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 124. ISRAEL CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 125. ISRAEL CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 126. ISRAEL CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. ITALY CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 128. ITALY CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 129. ITALY CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 130. ITALY CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. NETHERLANDS CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 132. NETHERLANDS CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 133. NETHERLANDS CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 134. NETHERLANDS CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. NIGERIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 136. NIGERIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 137. NIGERIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 138. NIGERIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. NORWAY CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 140. NORWAY CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 141. NORWAY CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 142. NORWAY CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. POLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 144. POLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 145. POLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 146. POLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. QATAR CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 148. QATAR CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 149. QATAR CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 150. QATAR CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 151. RUSSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 152. RUSSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 153. RUSSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 154. RUSSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 155. SAUDI ARABIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 156. SAUDI ARABIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 157. SAUDI ARABIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 158. SAUDI ARABIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 159. SOUTH AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 160. SOUTH AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 161. SOUTH AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 162. SOUTH AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 163. SPAIN CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 164. SPAIN CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 165. SPAIN CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 166. SPAIN CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 167. SWEDEN CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 168. SWEDEN CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 169. SWEDEN CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 170. SWEDEN CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 171. SWITZERLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 172. SWITZERLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 173. SWITZERLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 174. SWITZERLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 175. TURKEY CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 176. TURKEY CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 177. TURKEY CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 178. TURKEY CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 179. UNITED ARAB EMIRATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 180. UNITED ARAB EMIRATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 181. UNITED ARAB EMIRATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 182. UNITED ARAB EMIRATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 183. UNITED KINGDOM CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 184. UNITED KINGDOM CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 185. UNITED KINGDOM CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 186. UNITED KINGDOM CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 187. CANNABIS PHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 188. CANNABIS PHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 189. CANNABIS PHARMACEUTICALS MARKET LICENSE & PRICING

The Global Cannabis Pharmaceuticals Market is forecasted to grow significantly, with a projected USD 1,449.34 million in 2023 at a CAGR of 18.73% and expected to reach a staggering USD 4,826.56 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Cannabis Pharmaceuticals Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Cannabis Pharmaceuticals Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Brand, market is studied across Epidiolex and Sativex. The Epidiolex is projected to witness significant market share during forecast period.

Based on Product Type, market is studied across Ointments & Creams and Solids and Dissolvable Powder & Oil. The Solids and Dissolvable Powder & Oil is projected to witness significant market share during forecast period.

Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies. The Retail Pharmacies is projected to witness significant market share during forecast period.

Based on Application, market is studied across Arthritis, Cancer, Epilepsy, and Migraine. The Arthritis is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Cannabis Pharmaceuticals Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Cannabis Pharmaceuticals Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cannabis Pharmaceuticals Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cannabis Pharmaceuticals Market?

4. What is the competitive strategic window for opportunities in the Global Cannabis Pharmaceuticals Market?

5. What are the technology trends and regulatory frameworks in the Global Cannabis Pharmaceuticals Market?

6. What is the market share of the leading vendors in the Global Cannabis Pharmaceuticals Market?

7. What modes and strategic moves are considered suitable for entering the Global Cannabis Pharmaceuticals Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Cannabis Pharmaceuticals Market, by Brand, 2022 vs 2030
• 4.3. Cannabis Pharmaceuticals Market, by Product Type, 2022 vs 2030
• 4.4. Cannabis Pharmaceuticals Market, by Distribution Channel, 2022 vs 2030
• 4.5. Cannabis Pharmaceuticals Market, by Application, 2022 vs 2030
• 4.6. Cannabis Pharmaceuticals Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increase in the legalization of medicinal cannabis worldwide
    • 5.1.1.2. Growing awareness about the medical benefits of cannabidiol and its remedial properties
    • 5.1.1.3. Growing usage of cannabis-based pharmaceuticals for various indications such as inflammation, chronic pain, and sleep disorders
  • 5.1.2. Restraints
    • 5.1.2.1. High price associated with the medical cannabis
  • 5.1.3. Opportunities
    • 5.1.3.1. Rise in investments by pharma companies in CBD and developments for cannabinoid regulation
    • 5.1.3.2. Innovation and launching new products
  • 5.1.4. Challenges
    • 5.1.4.1. Availability of various alternatives in the market
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Cannabis Pharmaceuticals Market, by Brand

• 6.1. Introduction
• 6.2. Epidiolex
• 6.3. Sativex

7. Cannabis Pharmaceuticals Market, by Product Type

• 7.1. Introduction
• 7.2. Ointments & Creams
• 7.3. Solids and Dissolvable Powder & Oil

8. Cannabis Pharmaceuticals Market, by Distribution Channel

• 8.1. Introduction
• 8.2. Hospital Pharmacies
• 8.3. Online Pharmacies
• 8.4. Retail Pharmacies

9. Cannabis Pharmaceuticals Market, by Application

• 9.1. Introduction
• 9.2. Arthritis
• 9.3. Cancer
• 9.4. Epilepsy
• 9.5. Migraine

10. Americas Cannabis Pharmaceuticals Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Cannabis Pharmaceuticals Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Cannabis Pharmaceuticals Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. FPNV Positioning Matrix
• 13.2. Market Share Analysis, By Key Player
• 13.3. Competitive Scenario Analysis, By Key Player

14. List of Company Mentioned

15. Appendix

• 15.1. Discussion Guide
• 15.2. License & Pricing